<DOC>
	<DOCNO>NCT00235872</DOCNO>
	<brief_summary>The purpose study ass long-term safety tolerability repeat administration adalimumab Japanese subject rheumatoid arthritis .</brief_summary>
	<brief_title>Adalimumab Adult Japanese Subjects With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Participation completion Week 24 prior adalimumab doseranging study . Females must postmenopausal least 1 year , surgically sterile , practice birth control throughout study 90 day study completion . Female subject test negative pregnancy test ( serum test ) Week 24 prior adalimumab study , capable pregnancy . A subject experience follow prior study : Advanced poorly control diabetes Joint surgery ( joint evaluate study ) A subject prescribed exclude medication prior study . History follow prior study : Clinically significant drug alcohol abuse Intravenous ( iv ) drug abuse Active infection listeria tuberculosis ( TB ) Lymphoma , leukemia And , malignancy exception successfully treat nonmetastatic basal cell carcinoma skin . A subject administered live vaccine prior study , subject schedule complete administration live vaccine study period</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Rheumatoid arthritis</keyword>
</DOC>